Carolyn Rodriguez
Professor of Psychiatry and Behavioral Sciences; Associate Dean for Academic Affairs
Data updated
Research Footprint
Carolyn Rodriguez appears in 5 tracked papers (2015–2026), most studied alongside Ketamine, Placebo and MDMA, across Depressive Disorders, Anxiety Disorders and Neuroimaging & Brain Measures.
Most-cited paper: Psychedelics and Psychedelic-Assisted Psychotherapy (618 citations).
Frequent co-authors: Boris Heifets, Trisha Suppes and Xue Zhang.
Background & Research
Carolyn I. Rodriguez is a psychiatrist, neuroscientist, and clinical researcher at Stanford Medicine. She directs the OCD Research Lab and the Stanford Hoarding Disorders Research Program, and her research focuses on rapid-acting treatments, including ketamine and other neurobiological interventions, for severe psychiatric illness. She has also served as Deputy Editor of the American Journal of Psychiatry and is active in national psychiatry leadership.
Key Impact
She is a leading Stanford psychiatrist and clinical researcher whose work has helped advance rapid-acting treatments and circuit-based neuroscience approaches for OCD and related disorders.
Collaboration Network
8 collaborators· click a node to visit their profile
Full network →